← Leaderboards
Amin Arbabian
Stanford University
$2,583,858
Attributed
$2,583,858
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $750.1K · FY2018–22$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,583,858 · 2
By mechanism
R01$2,150,069 · 1
R21$433,789 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Katherine W Ferrara$45,937,231
- You Li$947,502
- Paul George$2,197,815
- David A Relman$34,583,734
- Layla Khalifehzadeh$914,122
Research focus
Non-Insulin-Dependent Diabetes MellitusFutureLeadTechnologyImpairmentPhysiologicalExperimental StudyIn VivoSmall MoleculeResponseDesignNew TechnologyDevicesPreventAcuteEquilibriumWireless TechnologyUltrasonographyMiniaturizationDiabetes MellitusDiabetes Mellitus TherapyDementiaAwarenessCoupled
Grant awards (6)
In vivo Wireless Sensors for Gut Redox Monitoring to Understand Host and Microbe Physiology$197,455
R21 · FY2022 · AI · contact PI
A Wireless, Implantable Microdevice for Closed-Loop Drug Delivery to Prevent the Morbidity of Diabetes Therapy-Induced Hypoglycemia$513,746
R01 · FY2021 · EB · contact PI
In vivo Wireless Sensors for Gut Redox Monitoring to Understand Host and Microbe Physiology$236,334
R21 · FY2021 · AI · contact PI
A Wireless, Implantable Microdevice for Closed-Loop Drug Delivery to Prevent the Morbidity of Diabetes Therapy-Induced Hypoglycemia$546,731
R01 · FY2020 · EB · contact PI
A Wireless, Implantable Microdevice for Closed-Loop Drug Delivery to Prevent the Morbidity of Diabetes Therapy-Induced Hypoglycemia$549,296
R01 · FY2019 · EB · contact PI
A Wireless, Implantable Microdevice for Closed-Loop Drug Delivery to Prevent the Morbidity of Diabetes Therapy-Induced Hypoglycemia$540,296
R01 · FY2018 · EB · contact PI